The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
Open accessAbstract
The availability of gene-targeted mice deficient in the urokinase-type plasminogen activator (uPA), urokinase receptor (uPAR), tissue-type plasminogen activator (tPA), and plasminogen permits a critical, genetic-based analysis of the physiological and pathological roles of the two mammalian plasminogen activators. We report a comparative study of animals with individual and combined deficits in uPAR and tPA and show that these proteins are complementary fibrinolytic factors in mice. Sinusoidal fibrin deposits are found within the livers of nearly all adult mice examined with a dual deficiency in uPAR and tPA, whereas fibrin deposits are never found in livers collected from animals lacking uPAR and rarely detected in animals lacking tPA alone. This is the first demonstration that uPAR has a physiological role in fibrinolysis. However, uPAR-/-/tPA-/- mice do not develop the pervasive, multi-organ fibrin deposits, severe tissue damage, reduced fertility, and high morbidity and mortality observed in mice with a combined deficiency in tPA and the uPAR ligand, uPA. Furthermore, uPAR-/-/tPA-/- mice do not exhibit the profound impairment in wound repair seen in uPA-/-/tPA-/- mice when they are challenged with a full-thickness skin incision. These results indicate that plasminogen activation focused at the cell surface by uPAR is important in fibrin surveillance in the liver, but that uPA supplies sufficient fibrinolytic potential to clear fibrin deposits from most tissues and support wound healing without the benefit of either uPAR or tPA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Plasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Physiological consequences of loss of plasminogen activator gene function in mice
Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D., & Mulligan, R. C. (1994) · Nature · doi:10.1038/368419a0 · Cited by 1,037
Self-citationCell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003
Beck, E., Ludwig, G., Auerswald, E. A., Reiss, B., & Schaller, H. (1982) · Gene · doi:10.1016/0378-1119(82)90023-3 · Cited by 921
SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGES
Unkeless, J. C., Gordon, S., & Reich, E. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.4.834 · Cited by 706
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Blasi, F., Vassalli, J., & Danø, K. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.4.801 · Cited by 617
Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.
HE, C. S., Wilhelm, S. M., Pentland, A. P., Marmer, B. L., Grant, G. A., Eisen, A. Z., & Goldberg, G. I. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2632 · Cited by 572
Impaired wound healing in mice with a disrupted plasminogen gene
Rømer, J., Bugge, T. H., Fyke, C., Lund, L. R., Flick, M. J., Degen, J. L., & Danø, K. (1996) · Nature Medicine · doi:10.1038/nm0396-287 · Cited by 561
Self-citationEstreicher, A., Mühlhauser, J., Carpentier, J. L., Orci, L., & Vassalli, J. D. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.783 · Cited by 469
Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.
Bugge, T. H., Flick, M. J., Daugherty, C. C., & Degen, J. L. (1995) · Genes & Development · doi:10.1101/gad.9.7.794 · Cited by 438
Self-citationResolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.
Suh, T. T., Holmbäck, K., Jensen, N. J., Daugherty, C. C., Small, K., Simon, D. I., Potter, S., & Degen, J. L. (1995) · Genes & Development · doi:10.1101/gad.9.16.2020 · Cited by 425
Self-citationEffects of Disruption of The Plasminogen Gene on Thrombosis, Growth, and Health in Mice
Ploplis, V. A., Carmeliet, P., Vazirzadeh, S., Van Vlaenderen, I., Moons, L., Plow, E. F., & Collen, D. (1995) · Circulation · doi:10.1161/01.cir.92.9.2585 · Cited by 386
Self-citationPrevention of metastasis by inhibition of the urokinase receptor.
Crowley, C. W., Cohen, R. L., Lucas, B. K., Liu, G., Shuman, M. A., & Levinson, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5021 · Cited by 374
The Molecular Basis of Blood Diseases
Baron, J. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520170097047 · Cited by 355
Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
Grainger, D. J., Kemp, P. R., Liu, A. C., Lawn, R. M., & Metcalfe, J. C. (1994) · Nature · doi:10.1038/370460a0 · Cited by 352
Generation and characterization of urokinase receptor-deficient mice.
Dewerchin, M., Nuffelen, A. V., Wallays, G., Bouché, A., Moons, L., Carmeliet, P., Mulligan, R. C., & Collen, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118489 · Cited by 231
Self-citationBugge, T. H., Suh, T. T., Flick, M. J., Daugherty, C. C., R, J., Solberg, H., Ellis, V., Danø, K., & Degen, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16886 · Cited by 218
Self-citationIn vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
Ossowski, L., Clunie, G., Masucci, M. T., & Blasi, F. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.4.1107 · Cited by 206
Plasminogen Activator Expression in Human Atherosclerotic Lesions
Lupu, F., Heim, D. A., Bachmann, F., Hurni, M., Kakkar, V. V., & Kruithof, E. K. O. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.9.1444 · Cited by 188
Altieri, D. C., Plescia, J., & Plow, E. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53932-6 · Cited by 181
Ossowski, L., Russo-Payne, H., & Wilson, E. L. (1991) · PubMed · Cited by 178
Odekon, L. E., Blasi, F., & Rifkin, D. B. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041580303 · Cited by 177
Mars, W. M., Liu, M.-L., Kitson, R. P., Goldfarb, R. H., Gabauer, M. K., & Michalopoulos, G. K. (1995) · Hepatology · doi:10.1002/hep.1840210631 · Cited by 167
Paroxysmal Nocturnal Hemoglobinuria
Rotoli, B., Nafa, K., & Risitano, A. M. (2007) · Principles of Molecular Medicine · doi:10.1007/978-1-59259-963-9_86 · Cited by 161
Rømer, J., Lund, L. R., Eriksen, J., Ralfkiaer, E. M., Zeheb, R., GELEHRTER, T. D., Danø, K., & Kristensen, P. K. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12486833 · Cited by 154
Rickles, R. J., Darrow, A. L., & Strickland, S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57341-0 · Cited by 152
Rømer, J., Lund, L. R., Eriksen, J., Pyke, C., Kristensen, P., & Danø, K. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12373187 · Cited by 143
Fibrin as a factor in atherogenesis
Smith, E. B., & Thompson, W. D. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90049-3 · Cited by 97
Kristensen, P. K., Eriksen, J., & Danø, K. (1991) · Journal of Histochemistry & Cytochemistry · doi:10.1177/39.3.1899685 · Cited by 94
Kramer, M. D., Schaefer, B., & Reinartz, J. (1995) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1995.376.3.131 · Cited by 33
Fibrin and Its Derivatives in the Normal and Diseased Vessel Wall
Bini, A., & Kudryk, B. J. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb51604.x · Cited by 20
Cited by
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., et al. (1998) · PubMed · doi:10.1182/blood.v91.10.3527 · Cited by 2,256
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
uPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Self-citationThe plasminogen activation system in tumor growth, invasion, and metastasis
Andreasen, P. A., Egelund, R., & Petersen, H. H. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050497 · Cited by 943
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins
Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 712
Metadata
- Authors
- Bugge, T. H., Flick, M. J., Danton, M. J., Daugherty, C. C., Romer, J., Dano, K., Carmeliet, P., Collen, D., & Degen, J. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-06-11
- Volume
- 93
- Issue
- 12
- Pages
- 5899-5904
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2100957812
- Cited by
- 276
- References
- 35
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.